Abstract :

Aims: The aim of this study to evaluate the possible aetiology of bleed & clinical profile of patients

Objectives:

• To assess the causes of the upper gastrointestinal haemorrhage.
• To assess the management of upper gastrointestinal bleeding.
• To review the complications of upper gastrointestinal haemorrhage.

Methodology:  A Hospital based prospective study was carried out for 6 months at single center, Warangal, Telangana, India. Patients were enrolled in this study based upon various symptoms and were assessed. Our study was used to define the possible etiology of bleed. All the relevant and necessary data was collected from patient’s care notes, Treatment charts Interviewing patient, Interviewing health care professional’s patient related information collected and confidentiality maintained.

Results: A total of 200 patients were enrolled in this study in which 11-80 years age using as subjects were enrolled from single centre. According to Gender wise 200 patients were divided 136(68%) males and 64(32%) females. According to Age wise categorization of the study population majority were in the age of 41-60(61%) years followed by age group 21-40 years(35.5%),61-80 years (9.5%) and 0-20 years (8.5 %) respectively. According to symptom wise distribution majority was found to be Hematemesis 106(53%) followed by Melena 77(39%) and both 17(9%) respectively.

Conclusion: In this study we found that Endoscopy can be used as diagnostic as well as therapeutic measures, it is therefore recommended within 24 hours of bleeding.

---

Keywords :

CLD (chronic liver disease), congestive gastropathy, hemorrhagic gastritis, UGIE(upeer gastrointestinal endoscopy).

---

References :

1. Kelvin Palmer. Acute upper gastrointestinal haemorrhage, Br Med Bull, 2007;83(1):307-24.
2. N. Barkun, M. Bardou, E. J. Kuipersetal. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding.AnnalsofInternalMedicine,2010;152(2):10113
3. Hearnshaw SA, Logan RF, Lowe D, et al. Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. Gut 2011;60:132735. [PubMed] [Google Scholar]
4. Kelvin Palmer. Acute uppergastrointestinalhaemorrhage, BrMed Bull, 2007;83(1):307-24
5. Acosta R.D.Differentialdiagnosis of upper gastrointestinal bleeding proximal to the ligament of Trietz.GastrointestEndoscClin N Am. 2011; 21: 555-566
6. Lee YT,WalmsleyRS,LeongRW,SungJJ, Dieulafoy’slesion. [2]Weston AP, Hiatal hernia with cameronulcers and erosions. Gastrointestinal endoscopyclinics of North America. 1996 Oct Sy
7. Stanley AJ,Laine L. Management of acute upper gastrointestinal bleeding. BMJ. 2019 Mar
8. Cooper AS. Interventions for Preventing Upper Gastrointestinal Bleeding inPeople Admitted to Intensive Care Units. Crit CareNurse. 2019 Apr;39(2):102-103. [PubMed]
9. Hwang JH, Fisher DA, Ben-Menachem T, et al. The role of endoscopy in the management of acute non-variceal upper GI bleeding. GastrointestEndosc 2012; 75:1132.
10. Laine L, Barkun AN, Saltzman JR, et al. ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding. Am J Gastroenterol 2021; 116:899.
11. https://www.uclahealth.org/radiology/ir/gastrointestinal-bleeding
12. https://www.medicalnewstoday.com/articles/upper-gi-bleed#summary
13. Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal haemorrhage: a population based study. Am J Gastroenterol 1995; 90:206-210.
14. https://www.emedicinehealth.com/gastrointestinal_bleeding/article_em.htm
15. Wilkins T, Khan N, Nabh A, Schade RR. Diagnosis and management of upper gastrointestinal bleeding. Am Fam Physician. 2012;85(5):469–76 .PubMedGoogle Scholar 
16. Enestvedt BK, Gralnek IM, Mattek N, et al. An evaluation of endoscopic indications and findings related to nonvariceal upper-GI hemorrhage in a large multicenter consortium. GastrointestEndosc2008;67:422-9. [Crossref] [PubMed]
17. Barkun A, Sabbah S, Enns R, et al. The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting. Am J Gastroenterol 2004;99:1238-46. [Crossref] [PubMed]
18. https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-017-0712-8
19. https://www.nejm.org/doi/full/10.1056/NEJMoa1912484
20. https://ijhcr.com/index.php/ijhcr/article/view/2913/2049
21. Allan R, Dykes P. A study of the factors influencing mortality rates from gastrointestinal haemorrhage. QJ Med. 1976;45:533–50. [PubMed]
22. Boley SJ, Sammartano R, Adams A, DiBiase A, Kleinhaus S, Sprayregen S. On the nature and etiology of vascular ectasias of the colon. Degenerative lesions of  Gastroenterology. 1977;72:650–60. [PubMed]
23. Rockall TA, Logan RF, Devlin HB, et al. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ1995;311:222–6. [PMC free article] [PubMed] [Google Scholar
24. de Groot NL, Bosman JH, Siersema PD, et al. Prediction scores in gastrointestinal bleeding: a systematic review and quantitative appraisal. Endoscopy2012;44:731–9. [PubMed] [Google Scholar]
25. PilottoA, FranceschiM, Leandro G, Paris F, Niro V, Longo MG, D’AmbrosioLP, AndriulliA, Di Mario F (2003). “The risk ofupper gastrointestinal bleeding in elderly users of aspirin and othernon-steroidal anti-inflammatory drugs: the role of gastroprotectivedrugs”. Aging Clin Exp Res. 15 (6): 4949. PMID 14959953.
26. HreinssonJP, KalaitzakisE, Gudmundsson S, BjrnssonES (2013). “Uppergastrointestinal bleeding: incidence, etiologyandoutcomes in a population-based setting”. Scand.J. Gastroenterol. 48 (4): 43947. doi:10.3109/00365521.2012.763174. PMC 3613943. PMID 23356751.
27. DriniM (2017). “Pepticulcer disease and non-steroidal anti-inflammatory drugs”. AustPrescr. 40 (3):9193. doi:10.18773/austprescr.2017.037. PMC 5478398. PMID 28798512.
28. KavianiMJ, PirastehfarM, Azari A, SaberifirooziM (2010). “Etiologyand outcome of patients with uppergastrointestinal bleeding: a study from South of Iran”. SaudiJ Gastroenterol. 16 (4): 2539. doi:10.4103/1319-3767.70608. PMC 2995092. PMID 20871188.
29. DavidsonAT (1985). “Uppergastrointestinal bleeding: causes and treatment”. JNatl Med Assoc. 77 (11): 9445. PMC 2571206. PMID 4078920.
30. van LeerdamME (2008). “Epidemiology of acute uppergastrointestinal bleeding”. Best PractResClin Gastroenterol. 22 (2): 20924. doi:10.1016/j.bpg.2007.10.011. PMID 18346679.
31. Morales Uribe CH, Sierra SierraS, HernndezHernndezAM, Arango Durango AF, LpezGA (2011). “Upper gastrointestinal bleeding: risk factors for mortality intwo urban centres in Latin America”. Rev EspEnfermDig. 103 (1): 204. PMID 21341933.
32. Rodrguez-HernndezH, Rodrguez-MornM, Gonzlez JL, Jquez-Quintana JO, RodrguezAcosta ED, Sosa-Tinoco E,Guerrero-Romero F (2009). “[Risk factors associated with uppergastrointestinal bleeding and with mortality]”. Rev Med Inst MexSeguro Soc (in Spanish; Castilian). 47 (2): 17984. PMID 19744387.
33. CorzoMaldonado MA, Guzmn Rojas P, Bravo ParedesEA, Gallegos Lpez RC, Huerta Mercado-Tenorio J, SurcoOchoa Y, ProchazkaZrateR, PiscoyaRivera A, Pinto Valdivia J, De losRosSenmacheR (2013).”[Risk factors associated to mortality by upper GI bleeding in patientsfrom a public hospital. A case control study]”. Rev GastroenterolPeru (in Spanish; Castilian). 33 (3): 2239. PMID 24108375.
34. Brooks J,Warburton R, Beales IL (2013). “Preventionof upper gastrointestinal haemorrhage: current controversies and clinicalguidance”. TherAdv Chronic Dis. 4 (5): 20622. doi:10.1177/2040622313492188. PMC 3752180. PMID 23997925.
35. Kim BS, LiBT, Engel A, Samra JS, Clarke S, Norton ID, Li AE (2014). “Diagnosisof gastrointestinal bleeding: A practical guide frclinicians”. World J GastrointestPathophysiol. 5 (4):46778. doi:10.4291/wjgp.v5.i4.467. PMC 4231512. PMID 25400991.
36. StruijkM, Postma DF, van TuylSA, van de ReeMA (2012). “Optimal drug therapyafter aspirin-induced upper gastrointestinal bleeding”. Eur. J.Intern. Med. 23 (3): 22730. doi:10.1016/j.ejim.2011.10.004. PMID 22385878.
37. Zhang YS,Li Q, He BS, Liu R, Li ZJ (2015). “Protonpump inhibitors therapy vs H2 receptor antagoniststherapy for upper gastrointestinal bleeding after endoscopy: Ametaanalysis”. World J.Gastroenterol. 21 (20): 634151. doi:10.3748/wjg.v21.i20.6341. PMC 4445112. PMID 26034370.
38. GurinA, ModyR,Carter V, AyasC, Patel H, LaschK, Wu E (2016). “Changesin Practice Patterns of Clopidogrel in Combination with Proton Pump Inhibitorsafter an FDA Safety Communication”. PLoSONE. 11 (1): e0145504. doi:10.1371/journal.pone.0145504. PMC 4699636. PMID 267
39. http://www.uptodate.com/contents/approach-to-acute-upper-gastrointestinal-bleeding-inadults.